pillbase.ru

BioTox Bac 2

Wirkstoff: CLOSTRIDIUM TETANI, CHLAMYDIA TRACHOMATIS, STREPTOCOCCUS VIRIDANS GROUP, NEISSERIA MENINGITIDIS, PHYTOLACCA AMERICANA ROOT, STREPTOCOCCUS PNEUMONIAE, CLOSTRIDIUM PERFRINGENS, SHIGELLA DYSENTERIAE, ENTEROCOCCUS FAECALIS, LISTERIA MONOCYTOGENES, STREPTOCOCCUS AGALACTIAE, STREPTOCOCCUS DYSGALACTIAE, STREPTOCOCCUS MUTANS, STREPTOCOCCUS EQUINUS, STREPTOCOCCUS UBERIS

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · CLOSTRIDIUM TETANI 15 [hp_X]/mL, CHLAMYDIA TRACHOMATIS 15 [hp_X]/mL, STREPTOCOCCUS VIRIDANS GROUP 15 [hp_X]/mL, NEISSERIA MENINGITIDIS 27 [hp_X]/mL, PHYTOLACCA AMERICANA ROOT 6 [hp_C]/mL, STREPTOCOCCUS PNEUMONIAE 12 [hp_C]/mL, CLOSTRIDIUM PERFRINGENS 15 [hp_C]/mL, SHIGELLA DYSENTERIAE 15 [hp_C]/mL, ENTEROCOCCUS FAECALIS 15 [hp_C]/mL, LISTERIA MONOCYTOGENES 15 [hp_C]/mL, STREPTOCOCCUS AGALACTIAE 15 [hp_C]/mL, STREPTOCOCCUS DYSGALACTIAE 15 [hp_C]/mL, STREPTOCOCCUS MUTANS 15 [hp_C]/mL, STREPTOCOCCUS EQUINUS 32 [hp_C]/mL, STREPTOCOCCUS UBERIS 32 [hp_C]/mL

Vereinigte StaatenAktiv

Zulassungsinhaber: The Wellness Center for Research and Education, Inc.

Geprüft 2026-10-09 · openFDA NDC

Zusammensetzung
  • CLOSTRIDIUM TETANI · 15 [hp_X]/mL
  • CHLAMYDIA TRACHOMATIS · 15 [hp_X]/mL
  • STREPTOCOCCUS VIRIDANS GROUP · 15 [hp_X]/mL
  • NEISSERIA MENINGITIDIS · 27 [hp_X]/mL
  • PHYTOLACCA AMERICANA ROOT · 6 [hp_C]/mL
  • STREPTOCOCCUS PNEUMONIAE · 12 [hp_C]/mL
  • CLOSTRIDIUM PERFRINGENS · 15 [hp_C]/mL
  • SHIGELLA DYSENTERIAE · 15 [hp_C]/mL
  • ENTEROCOCCUS FAECALIS · 15 [hp_C]/mL
  • LISTERIA MONOCYTOGENES · 15 [hp_C]/mL
  • STREPTOCOCCUS AGALACTIAE · 15 [hp_C]/mL
  • STREPTOCOCCUS DYSGALACTIAE · 15 [hp_C]/mL
  • STREPTOCOCCUS MUTANS · 15 [hp_C]/mL
  • STREPTOCOCCUS EQUINUS · 32 [hp_C]/mL
  • STREPTOCOCCUS UBERIS · 32 [hp_C]/mL
Zulassung
Zulassungsnummer
50181-0077
Zulassungsstatus
Aktiv
Abgabe
Rezeptfrei
Art der Anwendung
ORAL
Quellen